IL107547A - A skin healing system for the administration of physostigmine and a process for its production - Google Patents

A skin healing system for the administration of physostigmine and a process for its production

Info

Publication number
IL107547A
IL107547A IL10754793A IL10754793A IL107547A IL 107547 A IL107547 A IL 107547A IL 10754793 A IL10754793 A IL 10754793A IL 10754793 A IL10754793 A IL 10754793A IL 107547 A IL107547 A IL 107547A
Authority
IL
Israel
Prior art keywords
physostigmine
layer
therapeutic system
transdermal therapeutic
polymeric material
Prior art date
Application number
IL10754793A
Other languages
English (en)
Hebrew (he)
Other versions
IL107547A0 (en
Original Assignee
Lohmann Therapie Syst Lts
Neuwied And Klinge Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts, Neuwied And Klinge Pharma Gmbh filed Critical Lohmann Therapie Syst Lts
Publication of IL107547A0 publication Critical patent/IL107547A0/xx
Publication of IL107547A publication Critical patent/IL107547A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL10754793A 1992-11-12 1993-11-09 A skin healing system for the administration of physostigmine and a process for its production IL107547A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238223A DE4238223C1 (de) 1992-11-12 1992-11-12 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung

Publications (2)

Publication Number Publication Date
IL107547A0 IL107547A0 (en) 1994-02-27
IL107547A true IL107547A (en) 1996-12-05

Family

ID=6472735

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10754793A IL107547A (en) 1992-11-12 1993-11-09 A skin healing system for the administration of physostigmine and a process for its production

Country Status (32)

Country Link
US (1) US5698216A (xx)
EP (1) EP0667774B1 (xx)
JP (1) JP3407073B2 (xx)
KR (1) KR100254573B1 (xx)
CN (1) CN1088457A (xx)
AT (1) ATE156356T1 (xx)
AU (1) AU684256B2 (xx)
CA (1) CA2147274C (xx)
CZ (1) CZ284008B6 (xx)
DE (2) DE4238223C1 (xx)
DK (1) DK0667774T3 (xx)
EE (1) EE03135B1 (xx)
EG (1) EG20527A (xx)
ES (1) ES2105334T3 (xx)
FI (1) FI952269A0 (xx)
GR (1) GR3024720T3 (xx)
HR (1) HRP931391B1 (xx)
HU (1) HUT72963A (xx)
IL (1) IL107547A (xx)
LT (1) LT3107B (xx)
LV (1) LV10749B (xx)
MD (1) MD937C2 (xx)
MY (1) MY111373A (xx)
NO (1) NO306760B1 (xx)
NZ (1) NZ257136A (xx)
PL (1) PL172999B1 (xx)
RU (1) RU2108812C1 (xx)
SI (1) SI9300589A (xx)
SK (1) SK280185B6 (xx)
WO (1) WO1994010999A1 (xx)
YU (1) YU71293A (xx)
ZA (1) ZA938413B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
IL72684A (en) 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
DE3843239C1 (xx) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843238C1 (xx) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
JP4355469B2 (ja) * 2002-03-08 2009-11-04 日本碍子株式会社 アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法

Also Published As

Publication number Publication date
RU2108812C1 (ru) 1998-04-20
NO951864L (no) 1995-05-11
WO1994010999A1 (de) 1994-05-26
LT3107B (en) 1994-12-27
FI952269A (fi) 1995-05-10
CA2147274C (en) 2005-12-13
KR100254573B1 (ko) 2000-05-01
GR3024720T3 (en) 1997-12-31
MD940311A (en) 1998-03-31
AU684256B2 (en) 1997-12-11
DE4238223C1 (de) 1994-05-26
IL107547A0 (en) 1994-02-27
ZA938413B (en) 1994-06-09
JPH08502986A (ja) 1996-04-02
SK59395A3 (en) 1996-05-08
MY111373A (en) 1999-12-31
ATE156356T1 (de) 1997-08-15
YU71293A (sh) 1996-07-24
CZ124495A3 (en) 1996-01-17
CA2147274A1 (en) 1994-05-26
HU9501390D0 (en) 1995-06-28
EE03135B1 (et) 1998-12-15
SK280185B6 (sk) 1999-09-10
DK0667774T3 (da) 1998-03-23
ES2105334T3 (es) 1997-10-16
LV10749B (en) 1996-06-20
MD937B2 (xx) 1998-03-31
EG20527A (en) 1999-06-30
NZ257136A (en) 1996-07-26
LTIP1469A (en) 1994-06-15
NO951864D0 (no) 1995-05-11
HUT72963A (en) 1996-06-28
NO306760B1 (no) 1999-12-20
JP3407073B2 (ja) 2003-05-19
PL308531A1 (en) 1995-08-21
HRP931391A2 (en) 1995-02-28
CN1088457A (zh) 1994-06-29
AU5338594A (en) 1994-06-08
FI952269A0 (fi) 1995-05-10
CZ284008B6 (cs) 1998-07-15
EP0667774A1 (de) 1995-08-23
DE59307089D1 (de) 1997-09-11
PL172999B1 (pl) 1998-01-30
SI9300589A (en) 1994-06-30
US5698216A (en) 1997-12-16
HRP931391B1 (en) 1999-12-31
MD937C2 (ro) 1999-01-31
LV10749A (lv) 1995-08-20
KR950703948A (ko) 1995-11-17
EP0667774B1 (de) 1997-08-06

Similar Documents

Publication Publication Date Title
US5089267A (en) Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof
KR100300477B1 (ko) 활성성분으로서 갈란타민을 포함하는 경피치료시스템
CA2424579C (en) Ultraviolet-screening patch
KR950015057B1 (ko) 활성 성분으로서 피소스티그민을 포함하는 경피 치료계 및 이의 제조방법
US20130261571A1 (en) Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
KR19990062986A (ko) 경피 흡수형 제제
RU2440811C2 (ru) Устройство для трансдермального введения бисопролола
JP4466977B2 (ja) 経皮的治療システム
KR20010079513A (ko) 혈청 지질 수준에 영향을 미치는 적어도 하나의 유효물질을 함유하는 경피 플라스터
US5698216A (en) Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof
US5705186A (en) Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide
KR101764929B1 (ko) 셀레길린-함유 접착 제제
JPH062667B2 (ja) 貼付剤
JPH0753670B2 (ja) 経皮・経粘膜製剤
CA2410336A1 (en) Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
KR20030034692A (ko) 항염증제의 경피 조성물 및 장치

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees